Brandon Couillard
Stock Analyst at Wells Fargo
(4.67)
# 192
Out of 4,711 analysts
99
Total ratings
62.16%
Success rate
21.5%
Average return
Main Sectors:
Stocks Rated by Brandon Couillard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Overweight | $157 → $155 | $134.51 | +15.23% | 20 | Dec 9, 2024 | |
| MTD Mettler-Toledo International | Maintains: Equal-Weight | $1,400 → $1,350 | $1,230.74 | +9.69% | 2 | Nov 11, 2024 | |
| EXAS Exact Sciences | Maintains: Buy | $84 → $85 | $59.40 | +43.10% | 16 | Nov 6, 2024 | |
| BRKR Bruker | Maintains: Overweight | $78 → $75 | $57.00 | +31.58% | 2 | Nov 6, 2024 | |
| WAT Waters | Maintains: Overweight | $380 → $415 | $368.16 | +12.72% | 2 | Nov 4, 2024 | |
| WGS GeneDx Holdings | Maintains: Equal-Weight | $34 → $75 | $77.40 | -3.10% | 2 | Oct 30, 2024 | |
| AVTR Avantor | Maintains: Overweight | $30 → $28 | $21.21 | +32.01% | 2 | Oct 28, 2024 | |
| TMO Thermo Fisher | Maintains: Overweight | $670 → $660 | $524.05 | +25.94% | 2 | Oct 24, 2024 | |
| MYGN Myriad Genetics | Initiates: Overweight | $35 | $13.36 | +161.98% | 1 | Aug 27, 2024 | |
| RGEN Repligen | Initiates: Overweight | $180 | $144.46 | +24.60% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $10 | $5.37 | +86.22% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $120 | $132.08 | -9.15% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $28 | $20.61 | +35.86% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $340 | $327.47 | +3.83% | 7 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $340 | $325.85 | +4.34% | 7 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $130 | $112.56 | +15.49% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $280 | $228.55 | +22.51% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $74 → $81 | $69.82 | +16.01% | 5 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $30 → $23 | $18.70 | +22.99% | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $1.76 | +638.64% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $355 → $450 | $211.06 | +113.21% | 10 | Oct 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.64 | - | 11 | Nov 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $5.28 | +108.33% | 2 | Oct 13, 2017 |
Agilent Technologies
Dec 9, 2024
Maintains: Overweight
Price Target: $157 → $155
Current: $134.51
Upside: +15.23%
Mettler-Toledo International
Nov 11, 2024
Maintains: Equal-Weight
Price Target: $1,400 → $1,350
Current: $1,230.74
Upside: +9.69%
Exact Sciences
Nov 6, 2024
Maintains: Buy
Price Target: $84 → $85
Current: $59.40
Upside: +43.10%
Bruker
Nov 6, 2024
Maintains: Overweight
Price Target: $78 → $75
Current: $57.00
Upside: +31.58%
Waters
Nov 4, 2024
Maintains: Overweight
Price Target: $380 → $415
Current: $368.16
Upside: +12.72%
GeneDx Holdings
Oct 30, 2024
Maintains: Equal-Weight
Price Target: $34 → $75
Current: $77.40
Upside: -3.10%
Avantor
Oct 28, 2024
Maintains: Overweight
Price Target: $30 → $28
Current: $21.21
Upside: +32.01%
Thermo Fisher
Oct 24, 2024
Maintains: Overweight
Price Target: $670 → $660
Current: $524.05
Upside: +25.94%
Myriad Genetics
Aug 27, 2024
Initiates: Overweight
Price Target: $35
Current: $13.36
Upside: +161.98%
Repligen
Aug 27, 2024
Initiates: Overweight
Price Target: $180
Current: $144.46
Upside: +24.60%
Aug 27, 2024
Initiates: Overweight
Price Target: $10
Current: $5.37
Upside: +86.22%
Aug 27, 2024
Initiates: Underweight
Price Target: $120
Current: $132.08
Upside: -9.15%
Aug 27, 2024
Initiates: Underweight
Price Target: $28
Current: $20.61
Upside: +35.86%
Aug 27, 2024
Initiates: Equal-Weight
Price Target: $340
Current: $327.47
Upside: +3.83%
Aug 27, 2024
Initiates: Equal-Weight
Price Target: $340
Current: $325.85
Upside: +4.34%
Aug 27, 2024
Initiates: Equal-Weight
Price Target: $130
Current: $112.56
Upside: +15.49%
Aug 27, 2024
Initiates: Equal-Weight
Price Target: $280
Current: $228.55
Upside: +22.51%
Mar 6, 2024
Maintains: Hold
Price Target: $74 → $81
Current: $69.82
Upside: +16.01%
Feb 9, 2024
Downgrades: Hold
Price Target: $30 → $23
Current: $18.70
Upside: +22.99%
Jul 13, 2021
Initiates: Buy
Price Target: $13
Current: $1.76
Upside: +638.64%
Oct 22, 2020
Maintains: Buy
Price Target: $355 → $450
Current: $211.06
Upside: +113.21%
Nov 2, 2017
Downgrades: Hold
Price Target: n/a
Current: $3.64
Upside: -
Oct 13, 2017
Maintains: Buy
Price Target: $9 → $11
Current: $5.28
Upside: +108.33%